Swedish company Sigrid’s weight loss product Carb Fence has been recognised by the US Food and Drug Administration as a ...

Mainz Biomed has enrolled the first subject in its eAArly DETECT 2 feasibility study, aimed at evaluating colorectal cancer ...

UK's King's College London has spearheaded a trial that demonstrates AI can minimise the time required for 20-week pregnancy ...

Pantheon Vision has signed a deal with Eyedeal Medical to advance the manufacturing of its corneal implants for treating ...

Though late to the party compared to other industry mammoths, Abbott joins a pulsed field ablation market poised for ...

TOOsonix has formed a strategic collaboration with Consultronix to introduce its “focused” ultrasound skin therapy in Poland.

MedCAD has received 510(k) clearance from the US Food and Drug Administration (FDA) for its AccuStride Foot and Ankle System.

Aditxt subsidiary Pearsanta has acquired patents associated with adductomics-based DNA damage detection to advance cancer ...

Supira Medical has completed a $120m Series E funding round, with plans to use the capital to advance its position in the ...

The automated system, which helps cancer detection in dense breast tissue, can advance breast cancer screening pathways.

Abbott’s CGM device, the FreeStyle Libre, has been integrated with Glooko’s digital platform for diabetes management.

Splash Clinical and C2N Diagnostics have collaborated to enhance the recruitment process for clinical trials of Alzheimer's ...